Turkish Journal of Medical Sciences
Volume 29

Number 5

Article 7

1-1-1999

The Therapeutic Effect of Nifedipine as a Ca+2Entry Blocker on
Experimental TransientIschemic Retina
MURAT KAYA
CEMAL GÜNDOĞDU

Follow this and additional works at: https://journals.tubitak.gov.tr/medical
Part of the Medical Sciences Commons

Recommended Citation
KAYA, MURAT and GÜNDOĞDU, CEMAL (1999) "The Therapeutic Effect of Nifedipine as a Ca+2Entry
Blocker on Experimental TransientIschemic Retina," Turkish Journal of Medical Sciences: Vol. 29: No. 5,
Article 7. Available at: https://journals.tubitak.gov.tr/medical/vol29/iss5/7

This Article is brought to you for free and open access by TÜBİTAK Academic Journals. It has been accepted for
inclusion in Turkish Journal of Medical Sciences by an authorized editor of TÜBİTAK Academic Journals. For more
information, please contact academic.publications@tubitak.gov.tr.

Tr. J. of Medical Sciences
29 (1999) 541–544
© TÜBİTAK

Murat KAYA1
Cemal GÜNDOĞDU2

The Therapeutic Effect of Nifedipine as a Ca+2
Entry Blocker on Experimental Transient
Ischemic Retina

Received: July 15, 1997

Abstract: We evaluated the effect of nifedipine, an L-type voltage sensitive Ca+2 channel
(VSCC) blocker, on the onset of neuronal
damage induced by transient ischemia of
guinea pig retinas in vivo. The animals were
divided into two groups. In the first group 2
mg/kg Nifedipine was administered intraperitoneally, while only 2 cc/kg NaCl 0.9% solution was given to the second group thirty
minutes before the ischemic insult. Seven
days after the temporary ligation of bilateral
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Introduction
Ischemia may cause serious retinal damage with
disruption of the normal retinal cellular metabolism and
accumulation of cellular debris from disrupted axoplasmic
flow (1). Loss of cellular homeostasis and a shortage of
available adenosine triphosphate (ATP) causes the release
of glutamate and some other influxes of sodium, calcium
and chloride (2, 3). One of the most important causes of
neuronal damage is known to be influx and mobilization
of calcium (4, 5). In the literature some calcium
antagonists have been reported to prevent the neuronal
damage folowing ischemia by reducing the entry of Ca+2
into the cell and by increasing the blood flow into the
tissue (6-8).
Even though the prevention of neuronal dysfunction
by calcium antagonists has been well documented
especially in stroke and cerebral ischemia (9-11), only a
few studies have been performed on these drugs in ocular
ischemia (12-13).
In this experiment we aimed to detect and
demonstrate the neuroprotective effect of Nifedipine, an
L-type voltage sensitive Ca+2 channel blocker, on the
ischemic retinas of guinea pigs.
Materials and Methods

common carotid arteries for 45 minutes, the
animals were dispatched and the eyes were
enucleated for histopathologic analysis. It
was observed that in the Nifedipine treated
group, ganglion cells of the sensorial retina
were well preserved.
Key Words: Nifedipine, Ischemia, Retina,
VSCC Blocker.

used in our experiment. The animals were divided into
two groups each consisting of 6 guinea pigs. In the first
group 2 mg/kg nifedipine was administered
intraperitoneally while only 2 cc/kg NaCl 0.9% solution
was given to the second group in the same way, thirty
minutes before the ischemic insult.
Following a deep anesthesia with 40 mg/kg ketamin
intra muscularly, the animals were immobilized by fixing
their legs and the the head and neck were fully extended.
After shaving the cervical region, a 2cm horizontal skin
incision was made. Using an operation microscope (Zeiss
OPMI-1) and microsurgical instruments, the common
carotid arteries wre dissected from the vagus and the
cervical sympathetic nerves. Then bilateral temporal
ligation of the common carotid arteries was performed
using microvascular clips, simultaneously, as we have
described previously (14). The enucleated eyes were fixed
in 10% neutral buffered formaldehyde solution,
dehydrated in graded alcohols and embedded in paraffin.
Sections of the whole eye were stained with hematoxylin
and eosin. The histologic sections of the eyes were
examined. With high power fields (10x40) ganglion cells
of the sensorial retina in the peripapillary region and
posterior pole were counted. At least three areas on each
slide were examined and then the average number of
intact ganglion cells per slide calculated. The statistical

The eyes of 12 guinea pigs weighing 250-530 g were
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Figure 1.

Retinal ganglion cells were well preserved in the Nifedipine
treated group (H&E X400)

analysis was carried out using the unpaired student’s t
test.
Results
In group I, to which Nifedipine was applied during the
preischemic period, the number of ganglion cells and the
structure of inner retina were more preserved (Figure 1),
while in group II, to which only saline solution was applied
during the preischemic period, the number of intact
ganglion cells was lower (Figure 2, 3). A statistically
significant difference was found between the control
group and the Nifedipine treated group as shown in table
1 (t=2.805, p=0.0103 p<0.05).
Discussion
In this study Nifedipine, an L type voltage sensitive
calcium channel blocker, was found to be effective in
experimental transient ischemic retina for 45 minutes.
Since the important involvement of extracellular calcium
in the neurodegenerative process induced by excitatory
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Figure 2.

Number of intact ganglion cells were lower in the control
group (H&E X400)

amino acids in ischemia was observed, a number of
attempts were made to evaluate the possible
neuroprotective effect of calcium channel blockers.
Neuronal cells, especially intact neurons which surround
the ischemic area secrete glutamate during ischemia.
Glutamate is an important excitatory amino acid (EAA) in
many central nervous system synapses and with the other
neurotransmitters it causes calcium and sodium influx and
finally cell death during ischemia (15). This neurotoxicity
occurs via rapid (activiation of NMDA receptors) and slow
(activation of non NMDA-AMPA/quisqualate and kainate
receptors) pathways (16). During the ischemia, the
activation of the voltage sensitive calcium channels by
glutamate by non NMDA receptors are primarily
responsible for calcium influx and neuronal cell death
(17). In retinal cells, Ca+2 influx is induced through
AMPA/KA receptor (non NMDA) stimulation (18). Using
the patch-clamp technique, the presence of non NMDA
Na/Ca channels in retinal neurons have also been
demonstrated (19). To evaluate the possible
neuroprotective effect of calcium channel blockers, some
important studies have been made. In the primary culture
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Table 1.

Average number of ganglion cells

Number

Nifedipine

Control

Group

Group

1

52.33

27.66

2

67.00

68.33

3

70.33

29.00

4

46.00

68.00

5

71.33

29.66

6

70.66

27.66

7

52.00

26.00

8

69.00

11.33

9

68.33

11.66

10

44.00

52.66

11

52.33

67.66

12

68.00

68.33

Mean±

60.94±3.06

40.66±6.55

SEM
Unpaired student-t test results:
t=2.805

Figure 3.

Pyknosis and thin sensorial retina was observed in the control group (H&E X400)

of rat cerebellar granule cells, Pizzi has found that
Nifedipine used at 100nm concentration significantly
counteracted the neuronal death induced by 15 min.
application of 50um glutamate (20). Crosson also has
reported that Nifedipine had a potential therapeutic effect
on ischemic retinal dysfunction (21). In all these
experiments, nifedipine was found to be effective in
inhibiting Ca+2 influx into the cell. Contrary to these
report, Koh and Cotman have reported that in their in
vitro experiment a decrease in intraneuronal calcium
levels may trigger synthesis of proteins mediating cell
death (22). Some other in vitro experiments have

p=0.0103 (p<0.05)

revealed only a slight effect of calcium channel blockers
on neuronal cell loss. However these studies were in vitro
and in vitro experiments have revealed only a slight effect
of these compounds. On the other hand, it is well known
that ischemia has an effect on reducing tissue ATP levels;
especially Ca+2 reduces the capacity of the mitochondria
to synthesize ATP. It is most likely that Nifedipine, raises
ATP levels by preventing Ca+2 influx into the cell as an
additional effect, the same as flupirtine (23).
In conclusion, our in vivo study indicates that
Nifedipine, as a Dihydropyridine Ca+2 antagonist, reduces
ischemic retinal ganglion cell death and it may be
recommended as a potent neuroprotective agent in retinal
ischemia.
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